NASDAQ:CLOV
Clover Health Investments, Corp.
Clover Health Investments, Corp.'s revenue grew 40.3% in fiscal 2025 to $1.9B. Return on average equity was −26.3%, and the diluted share count rose 4.5%.Summary generated from Clover Health Investments, Corp.'s SEC filings. Latest annual report filed Feb 27, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.9B
Revenue growth+40.3%
Revenue, 5-yr CAGR+23.4%
Net margin−4.4%
Return on equity−26.3%
Share count change+4.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,472 | 1,097 | 1,261 | 1,371 | 1,924 |
| Net income | −588 | −340 | −213 | −43 | −86 |
Recent filings
- 8-KRegulation FD disclosure
Oct 9, 2026 - 4Insider transaction report
Oct 7, 2026 - 4Insider transaction report
Oct 5, 2026 - 8-K/AAmended director or officer change
Sep 25, 2026 - 8-KDirector or officer change
Sep 24, 2026 - 8-KRegulation FD disclosure
Aug 20, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026